| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1430019A1 Sphingolipids |
| 06/23/2004 | EP1429807A2 Combination of a nsaid and a pde-4 inhibitor |
| 06/23/2004 | EP1429796A2 Peptide antiangiogenic drugs |
| 06/23/2004 | EP1429787A1 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429782A1 Modulation of vitamin storage |
| 06/23/2004 | EP1429781A2 Composition comprising nanoparticulate spironolactone |
| 06/23/2004 | EP1429780A1 Method of treating middle ear infections |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429776A2 Tricyclic indole derivatives as 5-ht ligands |
| 06/23/2004 | EP1429774A2 Stent coated with a substained-release drug delivery |
| 06/23/2004 | EP1429772A1 N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 06/23/2004 | EP1429768A1 Novel medicaments for inhalation |
| 06/23/2004 | EP1429767A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 06/23/2004 | EP1429766A1 Pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1429764A1 Compositions and methods for the treatment of cancer |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429760A1 Novel combination |
| 06/23/2004 | EP1429757A2 Crystalline forms of fluvastatin sodium |
| 06/23/2004 | EP1429755A1 Use of vitamin e succinate and antiandrogen combination |
| 06/23/2004 | EP1429754A1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 06/23/2004 | EP1429752A1 Neuroprotective treatment methods using selective inos inhibitors |
| 06/23/2004 | EP1429729A1 Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin |
| 06/23/2004 | EP1429723A1 Treating effects of excessive reactive oxygen species |
| 06/23/2004 | EP1429713A2 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 06/23/2004 | EP1429689A1 Rational drug therapy device and methods |
| 06/23/2004 | EP1429648A2 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1429602A1 Methods for treating disorders using plant extracts |
| 06/23/2004 | EP1353906B1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 06/23/2004 | EP1274698B1 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 06/23/2004 | EP1263932A4 Embryonic stem cells and neural progenitor cells derived therefrom |
| 06/23/2004 | EP1255753B1 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1237851A4 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1189620B1 Formulation comprising testosteron undecanoate and castor oil |
| 06/23/2004 | EP1169470B1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 06/23/2004 | EP1140108B1 Method and composition for treatment of female sexual dysfunction |
| 06/23/2004 | EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 06/23/2004 | EP1071427B1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 06/23/2004 | EP1066283B1 Substituted indolealkanoic acids |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP1024801B1 Method for regulating size and growth of vascularized normal tissue |
| 06/23/2004 | EP0871471B1 Compositions using morphogenic proteins and stimulatory factors |
| 06/23/2004 | CN1507491A Apoptosis promoter and inhibitor interacting with CGI-94 and method of screening the same |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1507451A Cyclosporin-pro-drug and use thereof as a medicament |
| 06/23/2004 | CN1507449A 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 06/23/2004 | CN1507448A N-But-3-Enyl norbuprenophine and its use as analgesic |
| 06/23/2004 | CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 06/23/2004 | CN1507441A Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507429A Extract from the pods of lupin seeds containing lupeol |
| 06/23/2004 | CN1507355A Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507350A N-acetylcysteine compositions and methods for the treatment and preventino of drug toxicity |
| 06/23/2004 | CN1507347A Coated granules based on angiotensin-converting enzyme inhibitor |
| 06/23/2004 | CN1506105A Chinese patent medicine for preventing and treating post-operation blood stasis and its prepn process |
| 06/23/2004 | CN1506082A Beverage capable of turning white hair into black hair |
| 06/23/2004 | CN1506075A Cell growth regulating factor V and its prepn process |
| 06/23/2004 | CN1506066A Cell growth regulating factor oral liquid and its prepn process |
| 06/23/2004 | CN1506065A Cell growth regulating factor D and its prepn process |
| 06/23/2004 | CN1506064A Cell growth regulating factor E and its prepn process |
| 06/23/2004 | CN1506063A Cell growth regulatnig factor F and its prepn process |
| 06/23/2004 | CN1506062A Cell growth regulating factor G and its prepn process |
| 06/23/2004 | CN1506060A Cell growth regulating factor I and its prepn process |
| 06/23/2004 | CN1506059A Cell growth regulating factor K and its prepn process |
| 06/23/2004 | CN1506058A Cell growth regulating factor O and its prepn process |
| 06/23/2004 | CN1506057A Cell growth regulating factor Q and its prepn process |
| 06/23/2004 | CN1506056A Cell growth regulating factor R and its prepn process |
| 06/23/2004 | CN1506055A Cell growth regulatnig factor S and its prepn process |
| 06/23/2004 | CN1506054A Cell growth regulating factor U and its prepn process |
| 06/23/2004 | CN1506053A Cell growth regulating factor W and its prepn process |
| 06/23/2004 | CN1506052A Cell growth regulating factor X and its prepn process |
| 06/23/2004 | CN1505979A Nutritious composition |
| 06/23/2004 | CN1154744C Retroviral vectors that containing none of viral coding sequences |
| 06/23/2004 | CN1154650C Triazole-[4,5-d] pyrididines compound, its preparation, use and medical composition containing the same |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154496C Application of Odanpine of fluoxetine in medicine for treatment of refractory depression |
| 06/23/2004 | CN1154495C Use of mirtazapine for treating sleep apneas |
| 06/22/2004 | US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753346 CETP activity inhibitor |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/22/2004 | US6753328 Liver cancer; administering taurolidine |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | US6753326 14, 15-.α.-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |